Levitsky Hyam 4
4 · Century Therapeutics, Inc. · Filed Apr 14, 2023
Insider Transaction Report
Form 4
Levitsky Hyam
President of R&D
Transactions
- Award
Stock Option (right to buy)
2023-04-12+131,250→ 131,250 totalExercise: $2.91Exp: 2033-04-12→ Common Stock (131,250 underlying)
Footnotes (1)
- [F1]The option vests 25% on April 12, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.